Boston Scientific Corporation vs Ferrari NV — how do they compare? Boston Scientific Corporation trades at $51.05 (market cap $74.19B), while Ferrari NV trades at $406 (market cap $71.67B). The key difference: Boston Scientific Corporation and Ferrari NV are close in size by market cap, and Ferrari NV pays a 1.04% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | RACE | |
|---|---|---|
Market Cap | $74.19B | $71.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $108.14 | $504.09 |
52-Week Low | $42.63 | $314.63 |
Enterprise Value | $86.27B | $73.60B |
Dividend Yield | — | 1.04% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →